Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and kerbs von lungren 6 antigen in idiopathic pulmonary alveolar proteinosis

Mayo Clinic Proceedings

Volumn 83, Issue 12, 2008, Pages 1344-1349

  Lin, Fang Chi ^a,b   Chen, Yi Chu ^c   Chang, Shi Chuan ^b,c  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; KERBS VON LUNGREN 6 ANTIGEN; LACTATE DEHYDROGENASE; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; LUNG LAVAGE; MALE; OXYGEN TENSION; PROTEIN BLOOD LEVEL;

EID: 57349100935     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.12.1344     Document Type: Article

References (29)

1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med. 1958;258(23):1123-1142.
2. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002;166(2):215-235.
3. Shah PL, Hansell D, Lawson PR, Reid KBM, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax. 2000;55(1):67-77.
4. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med. 1999;190(6):875-880.
5. Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol. 2002;27(4):481-486.
6. Lin FC, Chang GD, Chern MS, Chen YC, Chang SC. Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis. Thorax. 2006 Jun;61(6):528-534. Epub 2006 Mar 3.
7. Iyonaga K, Suga M, Yamamoto T, Ichiyasu H, Miyakawa H, Ando M. Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis. Eur Respir J. 1999;14(2):383-389.
8. Meloni F, Alberti A, Bulgheroni A, et al. Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production. Eur Respir J. 2002;19(6):1128-1135.
9. Bonfield TL, John N, Malur A, et al. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression. Clin Immunol. 2005;114(1):79-85.
10. Bonfield TL, Swaisgood CM, Barna BP, Farver CF, Kavuru MS, Thomassen MJ. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor. J Leukoc Biol. 2006 Jan; 79(1):133-139. Epub 2005 Nov 7.
11. Hermans C, Bernard A. Pneumoproteinaemia: a new perspective in the assessment of lung disorders. Eur Respir J. 1998;11(4):801-803.
12. Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med. 1999;159(2):646-678.
13. Honda Y, Kuroki Y, Matsuura E, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med. 1995;152(6, pt 1):1860-1866.
14. Takahashi T, Munakata M, Suzuki I, Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 1998;158(4):1294-1298.
15. Tazawa R, Nakata K, Inoue Y, Nukiwa T. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report. Respirology. 2006;11(suppl):S61-S64.
16. Chou CW, Lin FC, Tung SM, Liou RD, Chang SC. Diagnosis of pulmonary alveolar proteinosis: usefulness of Papanicolaou-stained smears of bronchoalveolar lavage fluid. Arch Intern Med. 2001;161(4):562-566.
17. Cheng SL, Chang HT, Lau HP, Lee LN, Yang PC. Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage. Chest. 2002;122(4):1480-1485.
18. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment: international consensus statement. Am J Respir Crit Care Med. 2000;161(2, pt 1):646-664.
19. American Thoracic Society. Statement on sarcoidosis. Am J Respir Crit Care Med. 1999;160(2):736-755.
20. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, Walz A. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med. 1994;149(3, pt 1):655-659.
21. Suga M, Iyonaga K, Ichiyasu H, Saita N, Yamasaki H, Ando M. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J. 1999;14(2):376-382.
22. Bourke SJ. Interstitial lung disease: progress and problems. Postgrad Med J. 2006;82(970):494-499.
23. Reynolds HY. Lung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s. Am J Respir Crit Care Med. 2005 Jan 15;171(2):98-102. Epub 2004 Nov 19.
24. Ohnishi H, Yokoyama A, Kondo K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung disease. Am J Respir Crit Care Med. 2002;165(3):378-381.
25. Al-Salmi QA, Walter JN, Colasurdo GN, et al. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease. Chest. 2005;127(1):403-407.
26. Kobayashi J, Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest. 1995;108(2):311-315.
27. Takahashi H, Fujishima T, Koba H, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000;162(3, pt 1):1109-1114.
28. Uchida K, Beck DC, Yamamoto T, et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med. 2007;356(6):567-579.
29. Miles EA, Rees D, Banerjee T, et al. Age-related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis. 2008 Jan;196(1):298-305. Epub 2006 Nov 21.